The computational biology market is predicted to have a notable growth owing to its wide use by biotechnology and pharmaceutical companies to reduce the incidences of late stage failures of their drugs and to thereby curb R&D expenditure. Computational biology is also assisting in reducing the extensive use of humans in trials and is therefore useful for pediatric trials, trials on pregnant women and orphan disease research.

1. Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics,
Pharmacogenomics, Pharmacokinetics, Human Simulation Software, Drug Discovery & Development)
Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
The computational biology market is predicted to have a notable growth owing to its wide use by
biotechnology and pharmaceutical companies to reduce the incidences of late stage failures of their drugs and
to thereby curb R&D expenditure. Computational biology is also assisting in reducing the extensive use of
humans in trials and is therefore useful for pediatric trials, trials on pregnant women and orphan disease
research.
This report analyses the global market for computational biology by two main types of studies-cellular
modeling and disease modeling. Each of these segments has been further analyzed by various studies with use
of simulation, right from drug discovery to drug development. The market has also been bifurcated on the
basis of tools which include databases, software and IT infrastructure. The computational biology services
market highlights the trend of in-house and contract computational biology. The end users market studies the
usage pattern of academic research institutes and commercial industry. All the above mentioned segments are
analyzed on the basis of market size in terms of USD million and their forecasts for the period 2012 to 2018
have also been provided. The CAGR (%) for each market segment has been estimated for the forecast period
2012 to 2018, considering 2011 as the base year. Geographically, this market has been divided into four
major regions which include North America, Europe, Asia and RoW (Rest of the world). Market sizes,
forecasts and % CAGR for each region have been provided. The major drivers, restraints, challenges and
growth opportunities and other qualitative dynamics have been considered in the market overview section of
this report.
The competitive landscape of this industry has been covered under market share analysis by key players. Our
recommendation chapter provides assistance to industry players on ways to enter this market or to establish
sustainable competitive advantage.
The global computational biology market is segmented as follows:
Computational Biology Market, By Types Cellular & Biological Simulation Computational Genomics
Computational Proteomics Pharmacogenomics Others (Transcriptomics/ Metabolomics) Disease Modeling
and Simulation Drug Discovery Target Identification Target Validation Lead Discovery Lead Optimization
Drug Development Preclinical Pharmacokinetics Pharmacodynamics Clinical trials Phase I Phase II Phase III
Human Body Simulation Software
Computational Biology Market, By Services In-House Contract
Computational Biology Market, By End Users Academics Industry/ Commercial Players
Computational Biology Market, By Geography North America Europe Asia Rest of the World (RoW)
Industry/ Commercial Players
table Of Content
chapter 1 Introduction
Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokineti

2. 1.1 Report Description
1.2 Market Segmentation
1.3 Scope Of The Report
1.4 Research Methodology
1.4.1 Sources
1.4.1.1 Secondary Research
1.4.1.2 Primary Research
1.4.1.3 Models
1.5 Assumptions
chapter 2 Executive Summary
2.1 Market Snapshot: Global Computational Biology Market (2011 & 2018)
2.2 Global Computational Biology Market, By Types, 2011 (usd Million)
chapter 3 Global Computational Biology Market Dynamics
3.1 Market Overview
3.2 Drivers
3.2.1 Failure Of Drug Candidates In Late Stage Of Clinical Trials
3.2.1.1 Average Cost To Develop One New Drug (1975 -2011) (usd Million)
3.2.1.2 Trend Of Rise In Failure Of Phase Ii Clinical Trials (2006- 2012)
3.2.1.3 Reasons For Failure (%) In Phase Ii & Phase Iii
3.2.2 Enhanced Computational Tools
3.2.3 Improved Government Funding &industrial Support
3.3 Restraints
3.3.1 Lack Of Standardization
3.3.2 Non-verified Predictive Models
3.4 Challenges
3.4.1 Shortage Of Skilled Resources
3.4.2 Data Storage
3.5 Opportunities
3.5.1 Cloud Computing
3.5.2 Modelling And Simulations In Paediatrics Drug Development
3.6 Porters Five Forces Analysis
3.6.1 Bargaining Power Of Suppliers
3.6.2 Bargaining Power Of Buyers
3.6.3 Threat Of New Entrants
3.6.4 Threat Of Substitutes
3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis: Global Computational Biology Market, By Geography
3.8 End User Analysis
Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokineti

3. 3.8.1 End User Analysis: Global Computational Biology Market, 2011 & 2018 (%)
chapter 4 Global Computational Biology Market, By Applications
4.1 Introduction
4.1.1 Cellular Modelling And Simulation
4.1.1.1 Computational Genomics
4.1.1.1.1 Global Computational Genomics Market Revenues, 2010 – 2018 (usd Million)
4.1.1.2 Computational Proteomics
4.1.1.2.1 Global Computational Proteomics Market Revenues, 2010 – 2018 (usd Million)
4.1.1.3 Pharmacogenomics
4.1.1.3.1 Global Computational Pharmacogenomics Market Revenues, 2010 – 2018 (usd Million)
4.1.1.4 Others (metabolomics/ Transcriptomics)
4.1.1.4.1 Global Computational Others (metabolomics/transcriptomics) Market Revenue, 2010 – 2018
(usd Million)
4.1.2 Disease Modelling And Simulation Applications / Cadd (computer Aided Drug Design)
4.1.2.1 Drug Discovery
4.1.2.1.1 Global Computational Drug Discovery Market Revenues, 2010 – 2018 (usd Million)
4.1.2.1.2 Target Identification
4.1.2.1.2.1 Global Computational Target Identification Market Revenues, 2010 – 2018 (usd Million)
4.1.2.1.3 Target Validation
4.1.2.1.3.1 Global Computational Target Validation Market Revenues, 2010 – 2018 (usd Million)
4.1.2.1.4 Lead Identification/discovery
4.1.2.1.4.1 Global Computational Lead Identification Market Revenues, 2010 – 2018 (usd Million)
4.1.2.1.5 Lead Optimization
4.1.2.1.5.1 Global Computational Lead Optimization Market Revenues, 2010 – 2018 (usd Million)
4.1.2.1 Drug Development
4.1.2.1.1 Preclinical
4.1.2.1.1.1 Global Computational Preclinical Trials Market Revenues, 2010 – 2018 (usd Million)
4.1.2.1.2 Clinical Trials
4.1.2.1.2.1 Global Computational Clinical Trials Market Revenues, 2010 – 2018 (usd Million)
4.1.2.1.2.2 Phase I
4.1.2.1.2.3 Global Computational Clinical Trials Phase I Market Revenues, 2010 – 2018 (usd Million)
4.1.2.1.2.4 Phase Ii
4.1.2.1.2.5 Global Computational Clinical Trials Phase Ii Market Revenues, 2010 – 2018 (usd Million)
4.1.2.1.2.6 Phase Iii
4.1.2.1.2.7 Global Computational Clinical Trials Phase Iii Market Revenues, 2010 – 2018 (usd
Million)
4.1.2.1.3 Human Body Simulation Software
4.1.2.1.3.1 Global Computational Human Simulation Software Market Revenues, 2010 – 2018 (usd
Million)
Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokineti

4. chapter 5 Global Computational Biology Market, By Tools
5.1 Overview
5.2 Database
5.2.1 Global Computational Biology Database Market Revenues, 2010 – 2018 (usd Million)
5.3 It Infrastructure (hardware)
5.3.1 Global Computational Biology Hardware Market Revenues, 2010 – 2018 (usd Million)
5.4 Analysis Software & Services
5.4.1 Global Computational Biology Software Market Revenues, 2010 – 2018 (usd Million)
chapter 6 Global Computational Biology Market, By Services
6.1 Overview
6.2 In-house Computational Biology
6.2.1 Global In-house Computational Biology Market Revenues, 2010 – 2018 (usd Million)
6.3 External/contract Computational Biology
6.3.1 Global Contract Computational Biology Market Revenues, 2010 – 2018 (usd Million)
chapter 7 Global Computational Biology Market, By Geography
7.1 Overview
7.2 North America
7.2.1 North America Computational Biology Market Revenues, 2010 – 2018 (usd Million)
7.3 Europe
7.3.1 Europe Computational Biology Market Revenues, 2010 – 2018 (usd Million)
7.4 Asia
7.4.1 Asia Computational Biology Market Revenues, 2010 – 2018 (usd Million)
7.5 Row
7.5.1 Row Computational Biology Market Revenues, 2010 – 2018 (usd Million)
chapter 8 Market Share Analysis
8.1 Market Share By Key Players
8.1.1 Global Computational Biology Market Share Analysis Of Key Players, 2011 (%)
chapter 9 Recommendations
9.1 Success Strategies
9.1.1 Rigorous Research And Development (r&d) Initiatives
9.1.2 Investing In Emerging Economies
9.1.3 Investing In High-end Technologies
9.1.4 Collaborations, Mergers And Acquisitions
9.2 Barriers To Be Considered
9.2.1 High Cost Of Investment
Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokineti

5. chapter 10 Company Profiles
10.1 Accelrys
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Product Portfolio And Services
10.1.4 Business Strategy
10.1.5 Recent Developments
10.2 Certara
10.2.1 Company Profile
10.2.2 Financial Overview
10.2.3 Product Portfolio And Services
10.2.4 Business Strategy
10.2.5 Recent Developments
10.3 Chemical Computing Group Inc.
10.3.1 Company Profile
10.3.2 Financial Overview
10.3.3 Product Portfolio
10.3.4 Business Strategy
10.3.5 Recent Developments
10.4 Compugen, Ltd
10.4.1 Company Profile
10.4.2 Financial Overview
10.4.3 Business Strategy
10.4.4 Recent Developments
10.5 Entelos
10.5.1 Company Profile
10.5.2 Financial Overview
10.5.3 Product Portfolio And Services
10.5.4 Business Strategy
10.5.5 Recent Developments
10.6 Genedata Ag
10.6.1 Company Profile
10.6.2 Financial Overview
10.6.3 Product Portfolio And Services
10.6.4 Business Strategy
10.6.5 Recent Developments
10.7 Insilico Biotechnology Ag
10.7.1 Company Profile
10.7.2 Financial Overview
10.7.3 Product Portfolio
10.7.4 Business Strategy
Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokineti

6. 10.7.5 Recent Developments
10.8 Leadscope, Inc
10.8.1 Company Profile
10.8.2 Financialoverview
10.8.3 Product Portfolio
10.8.4 Business Strategy
10.8.5 Recent Developments
10.9 Nimbus Discovery Llc
10.9.1 Company Profile
10.9.2 Financial Overview
10.9.3 Product Portfolio
10.9.4 Business Strategy
10.9.5 Recent Developments
10.10 Rhenoviapharma Sas
10.10.1 Company Profile
10.10.2 Financial Overview
10.10.3 Product Portfolio And Services
10.10.4 Business Startegy
10.10.5 Recent Developments
10.11 Schrodinger
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Product Portfolio And Services
10.11.4 Business Strategy
10.11.5 Recent Developments
10.12 Simulation Plus, Inc.
10.12.1 Company Profile
10.12.2 Financial Overview
10.12.3 Product Portfolio And Services
10.12.4 Business Strategy
10.12.5 Recent Developments
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokineti

7. Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokineti